Loading...

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 1,267 results.

Thumbnail for Superior 96-weeks MMR rates and safety with generic Dasatinib-50mg in newly diagnosed CML : Large Real-world multicentre study from India

CML - 1655

Superior 96-weeks MMR rates and safety with generic Dasatinib-50mg in newly diagnosed CML : Large Real-world multicentre study from India

Sujay Rainchwar

Poster Presenter: Sujay Rainchwar

Thumbnail for Pulmonary Embolism as a Contributing Cause of Death in U.S. Hematologic Malignancy Patients: A 26-Year National Trend Analysis Using CDC WONDER Multiple Cause-of-Death Data (1999–2024)

CML - 1754

Pulmonary Embolism as a Contributing Cause of Death in U.S. Hematologic Malignancy Patients: A 26-Year National Trend Analysis Using CDC WONDER Multiple Cause-of-Death Data (1999–2024)

Akshata Vaggar

Poster Presenter: Akshata Vaggar

Thumbnail for Pregnancy in Patients with Chronic Myeloid Leukemia in Uzbekistan: Local Experience of Management Under Conditions of Limited Molecular Monitoring and TKI Availability

CML - 233

Pregnancy in Patients with Chronic Myeloid Leukemia in Uzbekistan: Local Experience of Management Under Conditions of Limited Molecular Monitoring and TKI Availability

Jamshidbek Khudayberdiev

Poster Presenter: Jamshidbek Khudayberdiev

Thumbnail for Integrating Functional Cellular Profiling With Molecular Diagnostics for Early Prediction of TKI Resistance in CML: Beyond Mutational Analysis

CML - 261

Integrating Functional Cellular Profiling With Molecular Diagnostics for Early Prediction of TKI Resistance in CML: Beyond Mutational Analysis

Nipanshi Tyagi

Poster Presenter: Nipanshi Tyagi

Thumbnail for Deep molecular response duration predicts treatment-free remission in CML rescued after resistance, warning or major molecular response

CML - 310

Deep molecular response duration predicts treatment-free remission in CML rescued after resistance, warning or major molecular response

Delphine Rea

Poster Presenter: Delphine Rea

Thumbnail for Efficacy and Safety of Asciminib as Second-Line or Later Therapy in Chronic-Phase Chronic Myeloid Leukemia: An Updated Systematic Review and Meta-Analysis

CML - 426

Efficacy and Safety of Asciminib as Second-Line or Later Therapy in Chronic-Phase Chronic Myeloid Leukemia: An Updated Systematic Review and Meta-Analysis

Shivam Rainchwar

Poster Presenter: Shivam Rainchwar

Thumbnail for Artificial Intelligence in Chronic Myeloid Leukemia: Assessing the Accuracy and Clinical Utility of Large Language Models

CML - 457

Artificial Intelligence in Chronic Myeloid Leukemia: Assessing the Accuracy and Clinical Utility of Large Language Models

Berkha Rani

Poster Presenter: Berkha Rani

Thumbnail for Temporal And Ethnic Disparities in Mortality due to Hematologic Malignancies in the United States: A 25 Year Nationwide Retrospective Analysis

CML - 462

Temporal And Ethnic Disparities in Mortality due to Hematologic Malignancies in the United States: A 25 Year Nationwide Retrospective Analysis

Palwasha Farooqi

Poster Presenter: Palwasha Farooqi

Thumbnail for Event-Free Survival and Safety With Ponatinib in Patients With Chronic-Phase Chronic Myeloid Leukemia: 5-Year Follow-Up of OPTIC

CML - 516

Event-Free Survival and Safety With Ponatinib in Patients With Chronic-Phase Chronic Myeloid Leukemia: 5-Year Follow-Up of OPTIC

Michael Deininger

Poster Presenter: Michael Deininger

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.